Piotr Smolewski Selected Research

Proto-Oncogene Proteins c-akt (Protein Kinase B)

1/2015	Novel target to kill CLL.
9/2014	Inhibition of the PI3K/Akt/mTOR signaling pathway in diffuse large B-cell lymphoma: current knowledge and clinical significance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Piotr Smolewski Research Topics

Disease

36	Neoplasms (Cancer) 08/2023 - 05/2004
20	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2022 - 05/2003
12	Lymphoma (Lymphomas) 11/2023 - 05/2004
8	Multiple Myeloma 08/2022 - 08/2008
8	Hematologic Neoplasms (Hematological Malignancy) 08/2022 - 07/2003
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 12/2004
6	Leukemia 09/2009 - 01/2002
5	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 01/2015
5	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 05/2019 - 05/2004
5	Breast Neoplasms (Breast Cancer) 12/2018 - 10/2011
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2023 - 12/2013
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2017 - 07/2004
3	Essential Thrombocythemia 12/2012 - 12/2009
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 07/2022 - 05/2019
2	Febrile Neutropenia 01/2022 - 01/2018
2	T-Cell Lymphoma (Lymphoma, T Cell) 06/2021 - 01/2017
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 01/2015
2	Disease Progression 05/2018 - 07/2006
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2015 - 12/2009
2	Necrosis 06/2013 - 11/2002
2	Thrombosis (Thrombus) 06/2010 - 12/2009
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2008 - 11/2005
2	Acute Promyelocytic Leukemia 05/2002 - 01/2002
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 11/2023
1	Agranulocytosis (Granulocytopenia) 11/2023
1	Cytopenia 11/2023
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 11/2023
1	Splenomegaly 11/2023
1	Second Primary Neoplasms (Neoplasms, Second) 01/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2020
1	Anemia 01/2020
1	Hypercalcemia (Milk Alkali Syndrome) 01/2020
1	Renal Insufficiency (Renal Failure) 01/2020

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2002
11	Monoclonal AntibodiesIBA 01/2021 - 05/2004
8	Cladribine FDA LinkGeneric 01/2019 - 05/2003
8	Rituximab (Mabthera)FDA Link 05/2018 - 05/2004
5	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2023 - 01/2018
5	Bortezomib (Velcade)FDA Link 08/2022 - 12/2006
5	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 09/2006
4	Proteasome InhibitorsIBA 08/2022 - 05/2019
4	Phosphotransferases (Kinase)IBA 02/2022 - 06/2006
4	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 01/2018
4	Vinblastine (Vinblastine Sulfate)FDA Link 01/2022 - 01/2018
4	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 01/2018
4	Brentuximab VedotinIBA 01/2022 - 01/2018
4	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2021 - 06/2006
4	CaspasesIBA 01/2021 - 11/2002
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2018 - 05/2003
3	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 01/2017
3	Inhibitor of Apoptosis ProteinsIBA 01/2021 - 02/2008
3	Clofarabine (Clolar)FDA Link 12/2018 - 01/2014
3	ranpirnase (Pannon)IBA 07/2014 - 02/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2013 - 06/2010
2	Dexamethasone (Maxidex)FDA LinkGeneric 08/2023 - 05/2019
2	Agammaglobulinaemia Tyrosine KinaseIBA 02/2022 - 01/2021
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022 - 01/2018
2	idelalisibIBA 01/2021 - 10/2020
2	Protein Isoforms (Isoforms)IBA 10/2020 - 12/2006
2	CytokinesIBA 01/2020 - 07/2004
2	PhytochemicalsIBA 12/2018 - 01/2015
2	retinoic acid receptor betaIBA 12/2018 - 01/2014
2	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2017 - 01/2014
2	Cytotoxins (Cytolysins)IBA 01/2017 - 03/2012
2	CD20 AntigensIBA 01/2016 - 05/2004
2	Cytostatic AgentsIBA 01/2016 - 02/2010
2	Immunomodulating AgentsIBA 09/2015 - 01/2015
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2015 - 09/2014
2	SurvivinIBA 01/2015 - 02/2008
2	SMIP-016IBA 10/2014 - 12/2009
2	fludarabineIBA 01/2014 - 12/2004
2	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 11/2002
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2009 - 08/2008
2	Etodolac (Lodine)FDA LinkGeneric 08/2008 - 12/2006
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 09/2006 - 11/2005
2	Purine NucleosidesIBA 01/2005 - 12/2004
2	Retinoic Acid Receptor alphaIBA 05/2002 - 01/2002
2	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA 05/2002 - 01/2002
1	Inosine Triphosphate (ITP)IBA 11/2023
1	MelatoninIBA 08/2023
1	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2022
1	6-bromo-2-naphthyl sulfate (BNS)IBA 07/2022
1	Messenger RNA (mRNA)IBA 02/2021
1	duvelisibIBA 01/2021
1	venetoclaxIBA 01/2021
1	ibrutinibIBA 01/2021
1	acalabrutinibIBA 01/2021
1	NF-kappa B (NF-kB)IBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 09/2020
1	ChemokinesIBA 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	CalciumIBA 01/2020

Therapy/Procedure

17	Therapeutics 08/2022 - 05/2004
11	Drug Therapy (Chemotherapy) 11/2022 - 09/2006
3	Immunotherapy 01/2018 - 01/2015
2	Hematopoietic Stem Cell Transplantation 08/2014 - 09/2013
1	Transplantation 01/2022